Pharmafile Logo
Pharmafocus logo
Advanced Search

Business Services

The latest news and analysis of the pharmaceutical and biotech business landscape. Including staff moves, product launches, acquisitions, mergers, collaborations and licensing agreements.

Showing 15 posts of 2378 posts found.

Aldeyra Therapeutics and AbbVie enter agreement for development and commercialisation of reproxalap

November 2, 2023 Business Services AbbVie, Aldeyra Therapeutics, Opthalmology, reproxalap

Aldeyra Therapeutics and AbbVie have announced that they have entered into an exclusive option agreement for the license to develop, …
News
glsun-mall-9xmv81sz5fw-unsplash

Samsung Biologics and Kurma Partners announce collaboration for development and manufacturing of biologics

October 24, 2023 Business Services Kurma Partners, Pharmacy, Samsung BioLogics

Samsung Biologics and Kurma Partners have announced a strategic partnership for the development and manufacturing of biologics for Kurma Partners’ …
News

Roche announces acquisition of Telavant

October 23, 2023 Business Services Gastrointestinal tract, Roche, Telavant

Roche has announced that it has entered into a definitive agreement to acquire Telavant Holdings, a Roivant company, owned by …
News

BMS acquires Mirati Therapeutics for $4.8bn

October 9, 2023 Business Services BMS, Mirati Therapeutics, Oncology, acquisition, bristol myers squibb, oncology

Bristol Myers Squibb (BMS) and Mirati Therapeutics have announced that they have entered into a definitive agreement under which BMS …
News

FUJIFILM Diosynth Biotechnologies appoints Maja Pedersen as chief quality officer

October 6, 2023 Business Services Fujifilm, Fujifilm Diosynth Biotechnologies, Maja Pedersen, Pharmacy, appointment, chief quality officer

CEO and president of FUJIFULM Diosynth Biotechnologies Lars Petersen has appointed Maja Pedersen as chief quality officer, where she will …
Appointment

Janssen and Sanofi enter agreement for potential vaccine programme

October 5, 2023 Business Services Immunology, Janssen, Sanofi, e coli, vaccines

Janssen Pharmaceuticals, a Johnson & Johnson company, has announced a development and commercialisation agreement with Sanofi for Janssen’s extraintestinal pathogenic …
News

Eli Lilly to acquire POINT Biopharma

October 4, 2023 Business Services Eli Lilly, Oncology, POINT Biopharma, acquisition, oncology

Eli Lilly and POINT Biopharma have announced a definitive agreement for Lilly to acquire POINT to expand its pipeline of …
News

Austrian state secretary to speak at FlyPharma Europe 2023

September 29, 2023 Business Services FlyPharma 2023, Vienna, flypharma

29 September 2023 — London, UK — FlyPharma Europe will welcome Mr Florian Tursky, the Austrian state secretary, to the …
News
Press release

Avalyn Pharma raises $175m in Series C financing for inhalation therapies

September 28, 2023 Business Services Avalyn Pharma, Financing, Pharmacy, funding, inhalation therapies

US-based clinical stage biopharmaceutical company Avalyn Pharma has announced that it has raised $175m in Series C financing to continue …
News

Alfasigma to acquire Intercept Pharmaceuticals for $19 per share

September 27, 2023 Business Services Alfasigma, Gastrointestinal tract, acquisition

Alfasigma and Intercept Pharmaceuticals have announced that they have entered into a definitive merger agreement, meaning Alfasigma will acquire Intercept …
News

Acesion Pharma raises €45m series B funding

September 26, 2023 Business Services Acesion Pharma, Cardiology, atrial fibrillation, series B financing

Acesion Pharma has announced that it has closed an oversubscribed €45m series B financing round. This financing was co-led by …
News

Exscientia enters AI drug discovery collaboration with Merck KGaA

September 20, 2023 Business Services AI, Exscientia, Immunology, Merck KGaA, Neurology, Oncology, collaboration, drug discovery

Exscientia has announced a new collaboration with Merck KGaA, Darmstadt, Germany, with a focus on the discovery of novel small …
News
towfiqu-barbhuiya-msqb97guxy0-unsplash

Abbott to acquire Bigfoot Biomedical

September 6, 2023 Business Services Abbott, Bigfoot Biomedical, Diabetes, acquisition, diabetes

Abbott and Bigfoot Biomedical have announced a definitive agreement for Abbott to acquire Bigfoot, however this transaction is still subject …
News

Novo Nordisk acquires Embark Biotech and its lead metabolic programme

August 31, 2023 Business Services Cardiology, Novo Nordisk, Obesity, acquisition, metabolics, obesity

Novo Nordisk has officially acquired the biopharmaceutical company Embark Biotech, along with its lead asset metabolic programme. The teams will …
News

CN Bio introduces Dr Tomasz Kostrzewski as new chief scientific officer

August 31, 2023 Business Services CN Bio, CSO, Dr Tomasz Kostrzewski, Microbiology

On 30August 2023, CN Bio announced the appointment of Dr Tomasz Kostrzewski as chief scientific officer (CSO) – a new …
Appointment

Latest content

Gilead shares phase 3 results from HIV prevention trial

June 21, 2024

Sarepta Therapeutics gains expanded FDA approval for DMD treatment

June 21, 2024

FDA approves AbbVie’s Skyrizi for UC treatment

June 20, 2024

Takeda shares data from phase 3 trial of CIPD treatment

June 20, 2024

EC grants marketing authorisation to Sobi’s Altuvoct for haemophilia A treatment

June 19, 2024